Excision biopsy of pigmented lesion of nail matrix
Abstract
Malignant melanoma is a malignancy originating from melanocytic cells of neuroectodermal origin. Despite it accounts for less than 2% of all cutaneous malignancies, it still has one of the worst prognosis among patients with these neoplasms. Acral lentiginous melanoma, including subungual melanoma, is one of the histologic subtypes of malignant melanoma of bad prognosis. Specific location causes diagnostic difficulties regarding the clinical follow-up, dermoscopic assessment and biopsy for histologic examination. In the current paper we have demonstrated an excisional biopsy of the pigmented lesion of nail matrix based on an example of a patient with subungual melanoma.
Keywords: subungual melanomanail matrixbiopsy
References
- American Cancer Society. Melanoma Skin Cancer 2015. http://www.cancer.org/cancer/skincancer-melanoma.
- Rutkowski P, Wysocki PJ, Nasierowska-Guttmejer A, et al. Cutaneous melanoma – diagnostic and therapeutic guidelines in 2016. OncolClinPract. 2015; 11: 216–231.
- Haneke E. Melanoma of the nail organ – diagnosis, differential diagnosis and treatment options. DermatolEstet. 2008; 10: 218–223.
- Kamińska-Winciorek G, Spiewak R. Dermoscopy on subungual melanoma. Postepy Hig Med Dosw (Online). 2013; 67: 380–387.
- Tosti A, Piraccini BM, de Farias DC. Dealing with melanonychia. Semin Cutan Med Surg. 2009; 28(1): 49–54.
- Jellinek N. Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. J Am Acad Dermatol. 2007; 56(5): 803–810.
